Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 20/20 | 0.61 |
| ▸ | TDO2 | P48775 | 13/20 | 0.61 |
| ▸ | CYP2C8 | P10632 | 4/20 | 0.61 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.61 |
| ▸ | CHRNA1 | P02708 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21061197 | 0.87 | IDO1 (0.64) | IDO1TDO2CYP2C8CYP2C9CHRNA1 | |
| SCHEMBL21061127 | 0.86 | IDO1 (0.69) | IDO1TDO2CYP2C8CYP2C9CHRNA1 | |
| Lithium Ion SCHEMBL21061146 | 0.83 | IDO1 (0.66) | IDO1TDO2CYP2C8CYP2C9CHRNA1 | |
| SCHEMBL21138091 | 0.81 | IDO1 (0.66) | IDO1TDO2CYP2C8CYP2C9CHRNA1 | |
| SCHEMBL21034703 | 0.80 | IDO1 (0.58) | IDO1TDO2CYP2C8CYP2C9CHRNA1 | |
| SCHEMBL29923819 | 0.80 | IDO1 (0.58) | IDO1TDO2CYP2C8CYP2C9CHRNA1 | |
| SCHEMBL21138420 | 0.79 | IDO1 (0.89) | IDO1TDO2CYP2C8CYP2C9CYP3A4 | |
| SCHEMBL20620323 | 0.79 | IDO1 (0.56) | IDO1TDO2CYP2C8CYP2C9CHRNA1 | |
| SCHEMBL17742812 | 0.79 | IDO1 (0.56) | IDO1TDO2CYP2C8CYP2C9CHRNA1 | |
| SCHEMBL19576473 | 0.79 | IDO1 (0.56) | IDO1TDO2CYP2C8CYP2C9CHRNA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019115586-A1 | OXALAMIDES AS MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE | Phenex Discovery Verwaltungs-GmbH (DE) | 2019-06-20 | — | — | WO | disclosed |